肝动脉栓塞治疗晚期原发性肝癌破裂大出血的临床应用(附45例分析)

Clinical application of hepatic artery embolization for treatment of massive hemorrhage due to advanced primary liver cancer rupture:an analysis of 42 cases

目的探讨肝动脉栓塞(TAE)治疗晚期原发性肝癌破裂大出血临床应用的价值和疗效。方法回顾性分析45例失去手术指征的晚期原发性肝癌破裂大出血患者急诊TAE治疗。其中8例在行TAE治疗的同时行肝动脉化疗栓塞术治疗。结果45例肝癌破裂出血患者全部止血成功,无复发性出血及急性肝功能衰竭发生。结论TAE是治疗晚期原发性肝癌破裂大出血安全、有效和首选的方法。

Objective To analyze the clinical value and therapeutic efficacy of hepatic artery embolization （TAE） for treatment of massive hemorrhage due to advanced primary liver cancer rupture. Methods Forty-five patients treated with TAE in emergency because of massive hemorrhage due to advanced liver cancer rupture without operative indication were retrospectively analyzed. Eight of the 45 patients were treated with TAE combined with transceatheter arterial chemoembolization. Results The hemostasis was successfully achieved in all of the 45 patients, and no recurrence of acute bleeding and liver failure occured. Conclusion TAE is a safe, effective method and first-choosed in the treatment of advanced primary liver cancer rupture.